We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$223M
AUM Growth
-$41.4M
Cap. Flow
-$38.1M
Cap. Flow %
-17.06%
Top 10 Hldgs %
11%
Holding
420
New
44
Increased
50
Reduced
231
Closed
47

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$2.06M
2
PBR icon
Petrobras
PBR
+$2M
3
VALE icon
Vale
VALE
+$1.96M
4
CQP icon
Cheniere Energy
CQP
+$1.94M
5
STR
Sitio Royalties
STR
+$1.94M

Top Sells

Rank Stock Value
1
BCC icon
Boise Cascade
BCC
+$2.62M
2
EXR icon
Extra Space Storage
EXR
+$2.49M
3
CNQ icon
Canadian Natural Resources
CNQ
+$2.46M
4
IMO icon
Imperial Oil
IMO
+$2.45M
5
AVNT icon
Avient
AVNT
+$2.42M

Sector Composition

Rank Sector Weight
1 Materials 20.16%
2 Real Estate 20.02%
3 Healthcare 16.51%
4 Energy 10.55%
5 Utilities 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
151
Amgen
AMGN
$212B
$421K 0.19%
1,740
– –
EVF
152
Eaton Vance Senior Income Trust
EVF
$89.9M
$414K 0.19%
65,061
+7,958
+14% +$52.6K
ACAD icon
153
Acadia Pharmaceuticals
ACAD
$4.45B
$392K 0.18%
16,172
– –
REGN icon
154
Regeneron Pharmaceuticals
REGN
$72.9B
$387K 0.17%
554
– –
ENTA icon
155
Enanta Pharmaceuticals
ENTA
$367M
$381K 0.17%
5,353
– –
PTCT icon
156
PTC Therapeutics
PTCT
$6.25B
$374K 0.17%
10,034
– –
SGEN
157
DELISTED
Seagen Inc. Common Stock
SGEN
$371K 0.17%
2,575
– –
TVTX icon
158
Travere Therapeutics
TVTX
$5.2B
$364K 0.16%
14,116
– –
TBPH icon
159
Theravance Biopharma
TBPH
$875M
$348K 0.16%
36,359
– –
BMRN icon
160
BioMarin Pharmaceuticals
BMRN
$12B
$346K 0.15%
4,486
– –
UTHR icon
161
United Therapeutics
UTHR
$26.1B
$344K 0.15%
1,918
– –
BIIB icon
162
Biogen
BIIB
$30.4B
$339K 0.15%
1,612
– –
FOLD
163
DELISTED
Amicus Therapeutics
FOLD
$339K 0.15%
35,800
– –
SRPT icon
164
Sarepta Therapeutics
SRPT
$1.63B
$339K 0.15%
4,345
– –
AGIO icon
165
Agios Pharmaceuticals
AGIO
$2.14B
$336K 0.15%
11,541
– –
OXSQ icon
166
Oxford Square Capital
OXSQ
$147M
$332K 0.15%
79,321
+10,159
+15% +$41.8K
RARE icon
167
Ultragenyx Pharmaceutical
RARE
$2.56B
$330K 0.15%
4,550
– –
SUNS
168
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
$328K 0.15%
23,152
-13,470
-37% -$188K
ALNY icon
169
Alnylam Pharmaceuticals
ALNY
$38.5B
$327K 0.15%
2,003
– –
INSM icon
170
Insmed
INSM
$22.6B
$326K 0.15%
13,869
– –
ASND icon
171
Ascendis Pharma A/S
ASND
$16.7B
$319K 0.14%
2,722
– –
SAGE
172
DELISTED
Sage Therapeutics
SAGE
$318K 0.14%
9,594
– –
FCRD
173
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$318K 0.14%
72,369
+10,648
+17% +$47.3K
MRCC
174
DELISTED
Monroe Capital Corp
MRCC
$317K 0.14%
29,383
-29,297
-50% -$319K
GILD icon
175
Gilead Sciences
GILD
$167B
$314K 0.14%
5,274
– –
5 6
7
8 9

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, Virtus ETF Advisers held 420 positions worth $223M, down 16% from $265M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Virtus ETF Advisers withdrew a net $38.1M in Q1 2022, closing 47 positions and reducing 231 holdings. Its most notable exit was Boise Cascade, an estimated $2.62M position sold in full.

By sector, the portfolio is most concentrated in Materials at 20% of assets, up from 14% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Virtus ETF Advisers opened a new position in The Mosaic Company worth $2.75M.

  • Virtus ETF Advisers's largest Q1 2022 buy was The Mosaic Company: 41,283 shares worth $2.75M.
  • Virtus ETF Advisers added most to Agnico Eagle Mines in Q1 2022, an estimated $1.28M increase.
  • Virtus ETF Advisers's biggest Q1 2022 reduction was Gold Fields, cutting an estimated $1.09M.
  • Virtus ETF Advisers fully exited Boise Cascade in Q1 2022, selling an estimated $2.62M.
  • Virtus ETF Advisers's ten largest holdings make up 11% of its $223M portfolio in Q1 2022.
  • Virtus ETF Advisers opened 44 new positions and closed 47 in Q1 2022.
  • Virtus ETF Advisers's portfolio value fell 16% quarter-over-quarter to $223M.

Based on Virtus ETF Advisers's 13F filing for Q1 2022, filed 16 May 2022.